AKI in hospitalized patients with and without COVID-19: a comparison study M Fisher, J Neugarten, E Bellin, M Yunes, L Stahl, TS Johns, ... Journal of the American Society of Nephrology 31 (9), 2145-2157, 2020 | 379 | 2020 |
Anticoagulation in COVID-19: effect of enoxaparin, heparin, and apixaban on mortality HH Billett, M Reyes-Gil, J Szymanski, K Ikemura, LR Stahl, Y Lo, ... Thrombosis and haemostasis 120 (12), 1691-1699, 2020 | 197 | 2020 |
Using automated machine learning to predict the mortality of patients with COVID-19: prediction model development study K Ikemura, E Bellin, Y Yagi, H Billett, M Saada, K Simone, L Stahl, ... Journal of medical Internet research 23 (2), e23458, 2021 | 70 | 2021 |
Methods for collection, storage and manipulation of sediments for chemical and toxicological analyses: technical manual K Zirbser, R Healy, L Stahl, B Tate, J Diamond, A Burton, M Johns, J Scott United States Environmental Protection Agency, Office of Science …, 2001 | 21 | 2001 |
P1‐231: Chronic BACE inhibition dramatically slows the rate of Aß accumulation and the development of amyloid plaques in young TgCRND8 mice L Hyde, X Chen, L Stahl, M Sondey, J Scott, J Cumming, A Stamford, ... Alzheimer's & Dementia 8 (4S_Part_5), P188-P188, 2012 | 4 | 2012 |
Using automated-machine learning to predict COVID-19 patient survival: identify influential biomarkers K Ikemura, DY Goldstein, J Szymanski, E Bellin, L Stahl, Y Yagi, M Saada, ... medRxiv, 2020.10. 12.20211086, 2020 | 3 | 2020 |
Discovery of a novel sulfone series of BACE1 inhibitors for Alzheimer's disease WL Wu, C Bennett, D Burnett, P Chen, J Cumming, M Domalski, E Gilbert, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 250, 2015 | 1 | 2015 |
Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin and Apixaban on Mortality (preprint) H Billett, MR Gil, J Szymanski, K Ikemura, L Stahl, Y Lo, S Rahman, ... | | 2020 |